Nalaganje...
Recurrent response to advanced lung adenocarcinoma with erlotinib developing leptomeningeal metastases during gefitinib therapy and two case reports
BACKGROUND: Epidermal growth factor-tyrosine kinase inhibitors (EGFR-TKIs) are one of the effective medicines in advanced lung adenocarcinoma leptomeningeal metastasis (LM) treatment in recent years. METHODS: This paper reports two cases of advanced lung adenocarcinoma with exon-EGFR19 mutation. LM...
Shranjeno v:
| izdano v: | Thorac Cancer |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BlackWell Publishing Ltd
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704275/ https://ncbi.nlm.nih.gov/pubmed/26766970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12049 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|